Formulation and method for treating neoplasms by inhalation

Details for Australian Patent Application No. 2001245412 (hide)

Owner BattellePharma, Inc.

Inventors Shah, Praful K.; Imondi, Anthony R.; Placke, Michael E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001245412

PCT Pub. Number WO01/66103

Priority 09517915 03.03.00 US

Filing date 2 March 2001

Wipo publication date 17 September 2001

Acceptance publication date 18 August 2005

International Classifications

A61K 031/00

Event Publications

11 March 2004 Assignment before Grant

  Battelle Memorial Institute The application has been assigned to BattellePharma, Inc.

18 August 2005 Application Accepted

  Published as AU-B-2001245412

15 December 2005 Standard Patent Sealed

22 December 2005 Corrigenda

  Applications Accepted - Name Index Under the name BattellePharma, Inc., Application No. 2001245412, under INID (54) correct the title to read Treatment of neoplasms by inhalation of carboplatin.

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001245413

2001245411-Design and discovery of protein based TNF-alpha variants for the treatment of TNF-alpha related disorders